🟡 60/100

Review before taking

  • Beta-Nicotinamide Mononucleotide: 250mg is 7.1× the Tolerable Upper Intake Level (35mg)
  • 100% of ingredients have research evidence
C Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ Beta-Nicotinamide Mononucleotide: 250mg is 7.1× the Tolerable Upper Intake Level (35mg)

The product received a low safety score because its dose of Beta-Nicotinamide Mononucleotide is over seven times higher than the recommended maximum daily limit.

Label Data

1 Capsule(s) Serving Size
60 Servings
Non-Nutrient/Non-Botanical Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

⚠️ Exceeds Tolerable Upper Intake Level by 7.1× (UL: 35 mg) 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 250mg UL 35mg

Other Ingredients

Gelatin Rice Flour

Label Claims — Verification

All Other
All Other (100% of products) Structure/Function (90% of products) Nutrient (2% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Directions: Take 1 capsule daily, or as advised by your doctor.

⚠️ Warnings & Precautions

Keep out of reach of children

Caution: If you suffer from any health problems or on medication check with your doctor first.

Vitamin supplements should not replace a balanced diet.

Additional Information

Store in a cool dry place

GMP Good Manufacturing Practice

Product Details

UPC / SKU 9 421906 923391
DSLD Entry Date 2024-02-22
Product Type Non-Nutrient/Non-Botanical
Form Capsule
DSLD ID 306102
Data Updated 2026-04-11

Research Evidence

8 Research Sources
54 Avg Quality Score
4 Rct
2 Meta Analysis
2 Clinical Trial
B Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis on randomized controlled trials
Meta Analysis Critical reviews in food science and nutrition 2025
B Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study
Rct GeroScience 2024
C Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women.
Rct Science (New York, N.Y.)
C The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial.
Rct GeroScience
C Effects of Nicotinamide Mononucleotide on Glucose and Lipid Metabolism in Adults: A Systematic Review and Meta-analysis of Randomised Controlled Trials
Meta Analysis Current diabetes reports 2024
C Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial
Rct Scientific reports 2023
C Safety and Pharmacokinetics of Nicotinamide Mononucleotide (NMN) in Healthy Adults.
Clinical Trial ClinicalTrials.gov 2021
C Effect of 'Nicotinamide Mononucleotide' (NMN) on Cardiometabolic Function
Clinical Trial ClinicalTrials.gov 2017
View all evidence for Nmn →

Compare Similar Products

View all Nmn products →